Researchers have identified a key mechanism in the development of Alzheimer’s disease involving the growth and pause of amyloid β fibrils.

A newly discovered antibody can lock these fibrils in their paused state, offering a potential new approach for treatment that targets these critical growth points.

Breakthrough in Alzheimer’s Research.